PRELIMINARY PROGRAM


15:00 - 16:00
Opening session
15:00 - 15:45
Ceremony of awarding the title of honorary member of the PTF to prof. Henryk I. Trzeciak


Laudation by prof. Ryszard Brus
Speech by prof. Henryk I. Trzeciak

15:45 - 16:00
Award ceremony for the best publication of PTF members
16:00 - 17:00
OPENING LECTURE
16:00 - 17:00
CEREBRAL VASCULAR PHARMACOLOGY OF THE ANTI-RETROVIRAL THERAPY
17:00 - 17:40
Oral session: PHARMACOLOGY IN ONCOLOGICAL DISORDERS
New aspects of oncological pharmacology
Nutraceuticals (functional food) - are they capable of exerting anticancer activity?
18:30
WELCOME RECEPTION
09:00 - 09:45
Room 1
THE USE OF PSYCHEDELICS FOR PSYCHIATRIC AND ADDICTIVE DISEASES
09:00 - 09:45
09:45 - 10:15
Coffee break
10:15 - 11:45
Room 1
Oral session: Phytopharmacology
Analgesic and antiinflammatory activity of Chelidonium majus alcaloids
Modulating effect of Scutellaria baicalensis and its flavonoids on the hypotensive effect of methyldopa in pregnant SHR rats
Urolithin A: gut-initiated neuroprotection in the battle against Parkinson's disease
Diabetes and the male reproductive system disorders - can plant neolignans help in combating its complications?
10:15 - 11:45
Room 2
Oral session: NEW APPROACHES IN PHARMACOTHERAPY
Investigating ancient-times compounds through the lens of AI: exploring new natural product-based treatments for COVID.
Targeting TRPM8 for the treatment of obesity: The role of neuronal TRPM8 signaling in the regulation of energy and glucose metabolism
Reduction of mitochondrial Activity by THC and CBD: Curse or Blessing?
Pleiotropic effects of PCSK-9 inhibitors
11:45 - 13:15
Poster session
12:00 - 13:15
Lunch
13:15 - 14:00
Room 1
Blood-brain barrier culture models and drug transport to the brain
13:15 - 14:00
Kostrzewa & Brus Lectureship
14:00 - 15:30
Room 1
Oral session: PHARMACOLOGY OF BLOOD-BRAIN BARRIER
Pericytes as potential therapeutic targets in cerebral pathologies
Methods to study the mechanisms of brain metastasis using in vitro models of the blood-brain barrier
Does the blood-brain barrier play a role in a stress response?
14:00 - 15:30
Room 2
Oral session: PHARMACOLOGY OF SKELETAL SYSTEM
Bones: interesting targets for drugs, risk factors, and food ingredients
The impact of cemtirestat treatment on bone parameters reflecting bone quality in rats with experimentally induced diabetes
Influence of Ilex extracts on bone metabolism in obese Zucker rats
Effects of Alzheimer's disease and its treatment on the skeletal system
15:30 - 16:00
Coffee break
16:00 - 17:30
Room 1
Oral sessions: ACADEMIC DRUG DEVELOPMENT IN HUNGARY. HUNGARIAN SOCIETY FOR EXPERIMENTAL AND CLINICAL PHARMACOLOGY (HUPHAR)
Drug developmental potential of miRNAs
Development of a novel multi-target drug candidate for neuropathic pain: preclinical and phase I clinical results
The somatostatin 4 receptor is a novel anti-inflammatory, analgesic and anti-depressant tar-get
Development of amiodarone metabolites for the treatment of atrial fibrillation
17:30 - 18:15
Room 1
AMANTADINE - A NEW LOOK AT THE OLD DRUG
17:30 - 18:15
19:00
GALA DINNER
Room 2
EDUCATIONAL SESSIONS (IN POLISH)
08:45 - 09:30
Room 2
ZAGROŻENIA CHEMICZNE I RADIACYJNE

Lecturer: Marek Kowalczyk (Warszawa, Polska)

09:30 - 11:30
Room 2
SESJA TEMATYCZNA: NOWOŚCI W FARMAKOLOGII KLINICZNEJ ORAZ FARMAKOTERAPII CHORÓB UKŁADU KRĄŻENIA I CHORÓB METABOLICZNYCH (we współpracy z Towarzystwem Farmakologii Klinicznej)

Transportery błonowe w farmakoterapii
Terapia spersonalizowana doustnymi bezpośrednimi antykoagulantami - rola farmakologa klinicznego
Czy powinniśmy obawiać się niskich stężeń cholesterolu LDL w prewencji pierwotnej i wtórnej choroby wieńcowej
Aktualne zasady terapii niealkoholowej stłuszczeniowej choroby wątroby - mechanizm działania i rola fosfolipidów podstawowych

Room 1
SCIENTIFIC SESSIONS
09:30 - 09:45
Room 1
PRESENTATION OF THE WINNING PAPER IN THE COMPETITION FOR THE BEST PUBLICA-TION BY PTF MEMBERS
09:45 - 10:20
Room 1
Oral session: NEUROPHARMACOLOGY I
The effect of valproate on the amino acids, monoamines and kynurenic acid level in the brain structures of the pentylenetetrazol kindled rats
Implications of NOP receptor system in the treatment of migraine-like symptoms.
10:30 - 11:30
Room 1
ORAL SESSION: NEUROPHARMACOLOGY II - HOW TO SUPPORT YOUR BRAIN FROM THE PERINATAL TO THE LATE AGE STAGE. A SEARCH FOR NEW PHARMACOTHERAPIES OF THE CENTRAL NERVOUS SYSTEM
How to prevent brain damage after birth asphyxia - problem still unresolved
Shaken, not stirred - in search for new potential pharmacotherapy of essential tremor
Polymeric nanocarriers for neuroprotective drug delivery to central nervous system
12:00 - 12:15
Closing Ceremony
12:30 - 14:00
Lunch

 

 

Host City

 

 

This website uses cookies. By continuing to browse, you are agreeing to our use of cookies. Please visit Privacy Policy to find out more.